← Back to Search

Behavioral Intervention

Violence Prevention Strategies for Youth Violence

N/A
Waitlist Available
Led By Terri Sullivan, PhD
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 14 through 24
Must not have
Youth younger than 14 and older than 24 will be excluded
Youth in grades below 9th
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 17 weeks after baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to reduce youth violence by using a hospital-based and universal prevention strategy that focuses on increasing community capacity for prevention.

Who is the study for?
This trial is for communities affected by youth violence, focusing on adolescents who have experienced domestic violence or other violent events. It aims to involve young people and community stakeholders in developing prevention strategies.
What is being tested?
The study tests 'Healthy Communities for Youth', a program combining the Emerging Leaders hospital-based intervention with universal strategies like participatory action research (PAR) to promote positive development and reduce youth violence.
What are the potential side effects?
Since this trial involves community programs rather than medical treatments, there are no traditional side effects. However, unintended consequences may include changes in community dynamics or resistance to new interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 14 and 24 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am between 14 and 24 years old.
Select...
I am in 8th grade or below.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 17 weeks after baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 17 weeks after baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Beliefs About Aggression and Alternatives (BAA)
Civic Engagement
Critical Consciousness
+8 more
Secondary study objectives
Adverse Childhood Experiences (ACES)
Behavior Assessment System for Children (BASC)
Developmental Assets Profile (DAP)
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Community BExperimental Treatment3 Interventions
Group II: Community AExperimental Treatment3 Interventions
Group III: Community CActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Centers for Disease Control and PreventionFED
887 Previous Clinical Trials
21,990,067 Total Patients Enrolled
Virginia Commonwealth UniversityLead Sponsor
714 Previous Clinical Trials
22,885,045 Total Patients Enrolled
Terri Sullivan, PhDPrincipal InvestigatorVirginia Commonwealth University
~1059 spots leftby Mar 2026